Prosight Management’s Longboard Pharmaceuticals LBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-321,154
Closed -$1.79M – 50
2023
Q3
$1.79M Sell
321,154
-413,743
-56% -$2.66M 0.57% 33
2023
Q2
$5.39M Sell
734,897
-165,703
-18% -$1.25M 1.58% 21
2023
Q1
$3.61M Buy
+900,600
New +$4.4M 1.71% 25

Other funds holding LBPH

Prosight Management's LBPH Position: Q4 2023 in Review

Prosight Management sold out of Longboard Pharmaceuticals (LBPH) in Q4 2023, closing a stake of 321,154 shares — an estimated $1.79M sold.

Prosight Management first reported a position in LBPH in Q1 2023 and held it in 3 quarters. The position peaked at $5.39M in Q2 2023. 52 funds tracked by Wall St. Rank hold LBPH as of Q4 2023.

  • Prosight Management reported no remaining Longboard Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Prosight Management sold 321,154 Longboard Pharmaceuticals shares in Q4 2023, an estimated $1.79M.
  • Prosight Management first reported a position in Longboard Pharmaceuticals in Q1 2023 and held it in 3 quarters.
  • Prosight Management's Longboard Pharmaceuticals position peaked at $5.39M in Q2 2023.
  • 52 funds tracked by Wall St. Rank held Longboard Pharmaceuticals as of Q4 2023.

Based on Prosight Management's 13F filing for Q4 2023, filed 14 Feb 2024.